NCT06492785 Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
| NCT ID | NCT06492785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwest Women's and Children's Hospital, Xi'an, Shaanxi |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 858 participants |
| Start Date | 2024-09-13 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 858 participants in total. It began in 2024-09-13 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.
Eligibility Criteria
Inclusion Criteria: 1. All cycles with single blastocyst transfer will be considered eligible 2. Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes 3. No age restriction will be applied 4. Informed consent was signed Exclusion Criteria: 1. Uterine anatomic anomalies 2. Women with untreated hydrosalpines 3. Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.
Contact & Investigator
Juanzi Shi, Doctor
STUDY CHAIR
Center for Reproductive Medicine, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, China
Frequently Asked Questions
Who can join the NCT06492785 clinical trial?
This trial is open to participants of all sexes, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06492785 currently recruiting?
Yes, NCT06492785 is actively recruiting participants. Contact the research team at caihe@bjmu.edu.cn for enrollment information.
Where is the NCT06492785 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT06492785 clinical trial?
NCT06492785 is sponsored by Northwest Women's and Children's Hospital, Xi'an, Shaanxi. The principal investigator is Juanzi Shi, Doctor at Center for Reproductive Medicine, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, China. The trial plans to enroll 858 participants.